14th CNAG symposium on genome research: Cancer Genomics

Unveiling the Secrets of Cancer through Genomics

Cancer is a multifaceted and constantly evolving condition, with the genome at its core. Viewing cancer through a genetic lens has transformed our understanding of its origins, development, and weaknesses. Genomic research is helping to unravel the biological processes that drive cancer, enabling earlier diagnoses, tailored treatments, and even preventive strategies.

This year, the CNAG 14th Symposium on Genome Research will focus on Cancer Genomics, bringing together over ten leading experts to share their pioneering work and discuss how genomic approaches are reshaping oncology. The programme will feature real-world success stories, from hereditary and colorectal cancers to leukaemia, breast cancer, and beyond.

These examples not only highlight the power of cutting-edge genomic research, but also show how science translates into hope for patients across the world. Join us on this journey through the genome, where science meets impact and data drives discovery.

Programme

Speakers

Registration

Venue

SESSION 1

09:45 - Sabine Tejpar, KU Leuven Research & Development (KU LEUVEN).

10:10 - Anna Pascual, Centro Nacional de Análisis Genómico (CNAG). “Tracing colorectal malignancy transformation from cell to tissue scale”.

10:35 - Sara Milosevic, 10x Genomics. “Discover innovative perspectives on biology through Single Cell & Spatial Techniques”.

10:50 - Eduard Batlle, ICREA & Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST). “Plasticity, theraphy resistance and immune evasion in metastatic colorectal cancer”.

11:15 - COFFEE BREAK

SESSION 2

11:45 - Sara Gutiérrez, Vall d'Hebron Institute of Oncology (VHIO). “Harnessing Germline Genomics for Personalized Radiotherapy and Improved Hereditary Cancer Diagnosis”.

12:10 - Matteo Spagnoletti, Roche. “Sequencing by expansion (SBX) - A versatile, high-throughput single-molecule sequencing technology".

12:25 - Marjanka Schmidt, Netherlands Cancer Institute (NKI), Leiden University Medical Center (LUMC). “The genomic footprint of breast cancer risk factors”.

12:50 - Nadia Sedlyarova, Illumina. “Beyond the genome with multiomics: Unlocking deeper biology”.

13:05 - LUNCH

SESSION 3

14:05 - Sergi Beltran, Centro Nacional de Análisis Genómico (CNAG). “Development of tools to facilitate cancer genomics data analysis and interpretation”.

14:30 - Vincenzo Lupo, Agilent. “Target Enrichment Approaches for Next-Generation Sequencing Applications in Oncology: an update from Agilent Technologies”

14:45 - Conxi Lazaro, Institut Català d’Oncologia - Instituto de Investigación Biomédica de Bellvitge (ICO-IDIBELL), Unitat de Cardio-Oncologia ICO-HUB. “National initiatives addressing unsolved hereditary cancer cases: From IMPaCT Genónima Cancer to IMPacT VUSCan functional genomics network”

15:10 - Roberto Piñeiro, Cancer Modelling Lab, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS). "Single-cell genomic profiling of Circulating tumor cells (CTCs) and CTC-cluster in stage IV Breast Cancer"

15:35 - Christophe Fleury, Oxford Nanopore Technologies. “From discovery to ultra rapid tumor profiling: The power of ultra rich Nanopore reads in cancer”.

15:50 - Ivo Gut, Centro Nacional de Análisis Genómico (CNAG). "Why would you go on a journey without a map?"

16:15 - VISIT TO CNAG FACILITIES


EDUARD BATLLE ICREA & Cancer Science Program Institute for Research in Biomedicine (IRB) The Barcelona Institute of Science and Technology (BIST)	SERGI BELTRAN Centro Nacional de Análisis Genómico (CNAG)


IVO GUT Centro Nacional de Análisis Genómico (CNAG)	SARA GUTIÉRREZ Vall d'Hebron Institute of Oncology (VHIO)


CONXI LAZARO Institut Català d’Oncologia - Instituto de Investigación Biomédica de Bellvitge (ICO-IDIBELL) Unitat de Cardio-Oncologia ICO-HUB	ANNA PASCUAL Centro Nacional de Análisis Genómico (CNAG)


ROBERTO PIÑEIRO Cancer Modelling Lab Translational Medical Oncology Group (Oncomet) Health Research Institute of Santiago de Compostela (IDIS)	MARJANKA SCHMIDT Netherlands Cancer Institute (NKI) Leiden University Medical Center (LUMC)


SABINE TEJPAR KU Leuven Research & Development (KU LEUVEN)

Participation in the 14th CNAG Symposium on Genome Research: Cancer Genomics is free of charge, but places are limited. To request a seat, please complete the registration form below with your details.

As the organizing center, CNAG will review all submissions and notify applicants by email regarding the confirmation of their attendance.

The 14th CNAG Symposium on Genome Research: Cancer Genomics will take place on Tuesday, 16 December 2025, from 09:00 to 16:30 at the Auditori Antoni Caparrós, located in the Parc Científic de Barcelona (Carrer Baldiri Reixac 4, Tower D, 08028 Barcelona).

Breakfast and lunch will be served adjacent to the auditorium.

From 16:30 onwards, participants will have the opportunity to join guided tours of the facilities at the National Center for Genomic Analysis, situated within the same complex. CNAG staff will accompany attendees from the auditorium to the tour location.

How to get there:

- Metro: L3 Palau Reial - L3 Zona Universitària.
- Tram: T1-T2-T3 Palau Reial - Zona Universitària - Av. Xile.
- Bus: 7, 33, 54, 60, 67, 75, 113, L12, L14, L79, L97, H6, H69.
- Bicing: 310 Josep Samitier / Joan XXIII.
- Plane: El Prat is situated 10km from the Parc Científic de Barcelona. To go by train from the airport, take Line 1 of the local train service (Renfe Rodalies) to the station 'Barcelona Sants', which has connections with the metro system (Line 3). By taxi the journey is 20 minutes.

We are grateful to our sponsors for their invaluable support, which makes the CNAG 14th Symposium on Genome Research possible. Their commitment helps advance cancer genomics and foster scientific discovery.